Andrew Davis

Andrew Davis

Corporate Officer/Principal bei DYNAVAX TECHNOLOGIES CORPORATION
40 Jahre
Health Technology
Consumer Services

Profil

Andrew Davis is currently Director at UTILITY therapeutics Ltd. since 2019 and Chief Business Officer at Dynavax Technologies Corp.
starting in 2024.
Formerly, Mr. Davis was Chairman at VectivBio Holding AG; Director at BioMarck Pharmaceuticals Ltd. from 2020 to 2022; Senior Vice President-Business Development at Ironwood Pharmaceuticals, Inc. in 2021; Senior Vice President-Business Development at Bausch Health US LLC from 2014 to 2016; Vice President-Corporate Development at Bausch Health Cos., Inc.; Chief Business Development Officer at iNova Pharmaceuticals (Pty) Ltd. (South Africa) from 2017 to 2021; and Head-Oncology Business Development at Merck & Co., Inc. from 2016 to 2017.
Education includes undergraduate studies at Boston University.

Aktive Positionen von Andrew Davis

UnternehmenPositionBeginn
DYNAVAX TECHNOLOGIES CORPORATION Corporate Officer/Principal 01.11.2024
Direktor/Vorstandsmitglied 01.08.2019

Ehemalige bekannte Positionen von Andrew Davis

UnternehmenPositionEnde
IRONWOOD PHARMACEUTICALS, INC. Corporate Officer/Principal 22.11.2024
Direktor/Vorstandsmitglied 01.10.2022
Corporate Officer/Principal 01.05.2021
MERCK & CO., INC. Corporate Officer/Principal 01.09.2017
Corporate Officer/Principal 01.01.2016
Sehen Sie sich die Erfahrung von Andrew Davis im Detail an

Ausbildung von Andrew Davis

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

15

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Andrew Davis